21 Invest-backed Omega Pharma completed the acquisition of Inpha.

21 Invest-backed Omega Pharma, food supplements, medical devices and cosmetics R&D and commercialization company, completed the acquisition of Inpha, a nutraceuticals researcher and developer. Financial terms were not disclosed. “This transaction represents a great growth opportunity for Inpha, which will find within the group the same focus on innovation and the scientific content of the products that we, as pharmacists, have always had. These are the key factors for sustainable long-term growth,” Giuseppe Samaritani and Simone Castelli, Inpha Founders.